chronic obstructive pulmonary disease
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed as stable COPD had stable condition without acute exacerbation in recent 4 weeks; 2. Pulmonary function classification of airflow restriction severity: GOLD-1-3; 3. Symptom assessment and risk of acute exacerbation: Group A and B; 4.40 = age = 80, male or female; 5. No history of infection or aggravation of respiratory system symptoms, no drug change or edema symptoms within 3 months before the start of the study; 6. Patients who can walk independently; 7. Patients without pulmonary rehabilitation in recent 6 months; 8. Good compliance, willing to cooperate with the study, and the patient signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with severe cardiovascular, cerebrovascular, nervous system, blood system, immune system, digestive system, thyroid dysfunction, chronic liver and kidney insufficiency, and malignant tumors; 2. Subjects with other concomitant active or clinically significant respiratory diseases that significantly affect the study: such as active pulmonary tuberculosis, bronchiectasis, pulmonary hypertension, pulmonary interstitial disease or other active pulmonary diseases; 3. Those who use long-term oxygen therapy (oxygen therapy time>15h/d) or mechanical ventilation; 4. Those who are not satisfied with blood pressure and blood glucose control; 5. People with a history of mental illness, intellectual disability, or mobility difficulties; 6. Pregnant or lactating women; 7. Those who have participated in other clinical trials in the past 6 months or at the same time.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FEV1 %pred; | — |
Secondary
| Measure | Time frame |
|---|---|
| Borg dyspnea scale;modified british medical research council;COPD assessment test;6-minute walk distance; | — |
Countries
China
Contacts
College of Acupuncture and Tuina, Chengdu University of Traditional Chinese Medicine